Grifols (GIKLY) Debt to Equity (2009 - 2025)
Grifols (GIKLY) posted Debt to Equity of $1.72 for Q4 2025, up 6.91% quarter-over-quarter from $1.61 in Q4 2024, and up 6.91% year-on-year from $1.61 in Q4 2024.
Grifols (GIKLY) Debt to Equity (2009 - 2025) Analysis & Trends
Grifols (GIKLY) has reported Debt to Equity for 16 consecutive years, with $1.72 the latest figure, recorded in Q4 2025.
- Debt to Equity for Q4 2025 came in at $1.72, up 6.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.72 (up 6.91% YoY), and the FY2025 annual result was $1.72, up 100.48% from the prior year.
- Debt to Equity was $1.72 for Q4 2025 at Grifols, up from $1.61 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.72 in Q4 2025 and troughed at $0.12 in Q4 2023.
- Average Debt to Equity over 5 years is $1.18, with a median of $1.28 recorded in 2022.
- Year-over-year, Debt to Equity slumped 90.31% in 2023 and surged 1203.81% in 2024.
- Over 5 years, Debt to Equity stood at $1.14 in 2021, then gained by 12.13% to $1.28 in 2022, then plunged by 90.31% to $0.12 in 2023, then soared by 1203.81% to $1.61 in 2024, then advanced by 6.91% to $1.72 in 2025.
- Per Business Quant data, the three most recent Debt to Equity figures were $1.72 in Q4 2025, $1.61 in Q4 2024, and $0.12 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.39 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.68 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.70 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.72 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | 1.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.72 |
| Dec 31, 2024 | 1.61 |
| Dec 31, 2023 | 0.12 |
| Dec 31, 2022 | 1.28 |
| Dec 31, 2021 | 1.14 |
| Dec 31, 2020 | -15.38 |
| Dec 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.02 |
| Dec 31, 2017 | 1.63 |
| Dec 31, 2016 | 0.02 |
| Dec 31, 2015 | 1.47 |
| Dec 31, 2014 | 1.63 |
| Dec 31, 2013 | 1.34 |
| Sep 30, 2013 | 1.40 |
| Jun 30, 2013 | 1.46 |
| Mar 31, 2013 | 1.45 |
| Dec 31, 2012 | 1.54 |
| Sep 30, 2012 | 1.55 |
| Jun 30, 2012 | 1.58 |
| Mar 31, 2012 | 1.62 |